Literature DB >> 21372295

Early inflammatory reactions in atherosclerosis are induced by proline-rich tyrosine kinase/reactive oxygen species-mediated release of tumor necrosis factor-alpha and subsequent activation of the p21Cip1/Ets-1/p300 system.

Asako Katsume1, Mitsuhiko Okigaki, Akihiro Matsui, Jishan Che, Yasushi Adachi, Eigo Kishita, Shinichiro Yamaguchi, Koji Ikeda, Tomomi Ueyama, Satoaki Matoba, Hiroyuki Yamada, Hiroaki Matsubara.   

Abstract

OBJECTIVE: Reactive oxygen species (ROS) are involved in the initial process of atherosclerosis, whereas it remains to be determined how atherogenic stimulus causes ROS-mediated proinflammatory reactions. Here, we focused on proline-rich tyrosine kinase (PYK2)-mediated ROS generation and examined how atherogenic stimulus causes early proinflammatory reactions. METHODS AND
RESULTS: PYK2-deficient (knockout [KO]) (PYK2-KO) mice were crossbred with apolipoprotein E (ApoE)-deficient (PYK2-KO/ApoE-KO) mice. PYK2-KO/ApoE-KO mice and endothelial cells (EC) were used for the study. Aortic atherogenic lesions in PYK2-KO/ApoE-KO mice were markedly decreased (55% versus ApoE-KO) after 8 weeks of a Western diet. Aortic PYK2 was activated as early as 7 days after the Western diet, when inflammatory cells were not yet activated. Addition of the proatherogenic oxidized phospholipid lysophosphatidylcholine caused activation of endothelial PYK2. Lysophosphatidylcholine-activated PYK2 induced NADPH oxidase-mediated ROS generation and ROS-mediated synthesis of tumor necrosis factor-α (TNFα), vascular cell adhesion molecule-1 (VCAM-1), monocyte chemotactic protein-1 (MCP-1), and p21Cip1/Ets-1. Neutralizing anti-TNFα antibody or knockdown of p21Cip1/Ets-1 system blocked the induction of VCAM-1 and MCP-1. PYK2 deficiency abolished these ROS-mediated proinflammatory reactions. Further analysis revealed that PYK2/ROS-mediated p21Cip1/Ets-1 activation upregulated the transcription of the MCP-1 gene in collaboration with p300 transcription coactivator.
CONCLUSIONS: PYK2 is a key tyrosine kinase activated by high cholesterol exposure, which causes ROS-mediated TNFα release and induces TNFα-dependent expression of proinflammatory molecules via the p21Cip1/Ets-1/p300 transcription system.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21372295     DOI: 10.1161/ATVBAHA.110.221804

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  16 in total

1.  ROS-dependent Syk and Pyk2-mediated STAT1 activation is required for 15(S)-hydroxyeicosatetraenoic acid-induced CD36 expression and foam cell formation.

Authors:  Sivareddy Kotla; Nikhlesh K Singh; James G Traylor; A Wayne Orr; Gadiparthi N Rao
Journal:  Free Radic Biol Med       Date:  2014-08-23       Impact factor: 7.376

2.  Ac2PIM-responsive miR-150 and miR-143 target receptor-interacting protein kinase 2 and transforming growth factor beta-activated kinase 1 to suppress NOD2-induced immunomodulators.

Authors:  Praveen Prakhar; Sahana Holla; Devram Sampat Ghorpade; Martine Gilleron; Germain Puzo; Vibha Udupa; Kithiganahalli Narayanaswamy Balaji
Journal:  J Biol Chem       Date:  2015-09-21       Impact factor: 5.157

3.  Infliximab relieves blood retinal barrier breakdown through the p38 MAPK pathway in a diabetic rat model.

Authors:  Mao-Song Xie; Yong-Zheng Zheng; Li-Bin Huang; Guo-Xing Xu
Journal:  Int J Ophthalmol       Date:  2017-12-18       Impact factor: 1.779

Review 4.  Redox balance dynamically regulates vascular growth and remodeling.

Authors:  Shyamal C Bir; Gopi K Kolluru; Kai Fang; Christopher G Kevil
Journal:  Semin Cell Dev Biol       Date:  2012-05-24       Impact factor: 7.727

Review 5.  Mitochondrial reactive oxygen species and risk of atherosclerosis.

Authors:  Maarten Hulsmans; Els Van Dooren; Paul Holvoet
Journal:  Curr Atheroscler Rep       Date:  2012-06       Impact factor: 5.113

6.  The transcription factor CREB enhances interleukin-17A production and inflammation in a mouse model of atherosclerosis.

Authors:  Sivareddy Kotla; Nikhlesh K Singh; Mark R Heckle; Gabor J Tigyi; Gadiparthi N Rao
Journal:  Sci Signal       Date:  2013-09-17       Impact factor: 8.192

Review 7.  Targeting vascular (endothelial) dysfunction.

Authors:  Andreas Daiber; Sebastian Steven; Alina Weber; Vladimir V Shuvaev; Vladimir R Muzykantov; Ismail Laher; Huige Li; Santiago Lamas; Thomas Münzel
Journal:  Br J Pharmacol       Date:  2016-07-04       Impact factor: 8.739

8.  Novel role of proline-rich nonreceptor tyrosine kinase 2 in vascular wall remodeling after balloon injury.

Authors:  Ravisekhar Gadepalli; Nikhlesh K Singh; Venkatesh Kundumani-Sridharan; Mark R Heckle; Gadiparthi N Rao
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-08-23       Impact factor: 8.311

9.  Hck/Fgr Kinase Deficiency Reduces Plaque Growth and Stability by Blunting Monocyte Recruitment and Intraplaque Motility.

Authors:  Céline Cougoule; Maik Drechsler; Indira Medina; Beatriz Bermudez; Rory R Koenen; Judith Sluimer; Ine Wolfs; Yvonne Döring; Veronica Herias; Marjon Gijbels; Ilze Bot; Saskia de Jager; Christian Weber; Jack Cleutjens; Theo J C van Berkel; Kees-Jan Sikkink; Atilla Mócsai; Isabelle Maridonneau-Parini; Oliver Soehnlein; Erik A L Biessen
Journal:  Circulation       Date:  2015-06-11       Impact factor: 29.690

10.  Novel role for p21-activated kinase 2 in thrombin-induced monocyte migration.

Authors:  Ravisekhar Gadepalli; Sivareddy Kotla; Mark R Heckle; Shailendra K Verma; Nikhlesh K Singh; Gadiparthi N Rao
Journal:  J Biol Chem       Date:  2013-09-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.